Sarepta Therapeutics Balance Sheet - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$29.93 $0.25 (0.84%) SRPT stock closing price Mar 24, 2017 (Closing)
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q4 2016-Q3 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Cash122.42M395.14M38M80.3M55.81M69.53M74.43M73.55M52.29M102.75M
Marketable Securities206.12M10.69M101.85M122.88M44.09M87.34M91.78M136.79M187.71M180.78M
Receivables5.23M3.98M3.99M3.97M2.73M2.41M2.41M2.41M3.36M5.22M
Inventory12.81M2.92M--------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets26.9M22M16.88M17.38M19.46M23.09M24.41M35.03M26.43M15.9M
Sarepta Therapeutics Total Current Assets
373.48M434.74M160.72M224.54M122.1M182.39M193.04M247.79M269.81M304.67M
Property Plant & Equipment68.15M64.04M62.8M61.93M60.74M59.38M58.79M58.39M56.04M38.1M
Accumulated Depreciation30.35M28.42M25.82M24.59M23.36M22.19M21.03M19.89M18.86M17.94M
Sarepta Therapeutics Net Property Plant & Equipment
37.8M35.62M36.98M37.34M37.37M37.19M37.75M38.5M37.17M20.16M
Investment & Advances0.78M0.78M0.78M0.78M11.47M0.78M0.78M0.78M0.64M0.64M
Other Non-Current Assets----------
Deferred Charges----------
Intangibles8.08M8.11M6.72M6.64M6.11M6.02M5.84M5.89M5.68M5.38M
Deposits & Other Assets3.97M8.05M8.14M4.47M7.67M5.31M5.27M2.06M5.72M6.44M
Sarepta Therapeutics Total Assets
424.1M487.31M213.36M273.78M184.75M231.71M242.7M295.03M319.05M337.3M
Notes Payable-2.49M--------
Accounts Payable29.69M20.68M18.67M20.23M7.43M14.09M9.31M12.4M0.96M1.3M
Current Portion Long-Term Debt10.11M10.1M7.6M5.93M3.43M0.1M0.09M0.09M0.09M0.09M
Current Portion Capital Leases----------
Accrued Expenses31.02M29.53M24.27M29.05M19.76M15.18M15.03M17.36M14.82M13.83M
Income Taxes Payable----------
Other Current Liabilities4.61M4.6M4.6M4.57M4.58M4.67M4.61M4.5M4.42M14.16M
Sarepta Therapeutics Total Current Liabilities
75.42M64.93M55.16M62.29M37.66M38.96M33.9M36.86M22.72M29.4M
Mortgages----------
Deferred Taxes/Income5.95M5.26M5.86M6.17M6.45M6.72M6.59M6.77M6.36M6.45M
Convertible Debt----------
Long-Term Debt6.04M8.49M13.37M14.96M17.39M20.65M1.45M3.73M3.76M1.52M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Sarepta Therapeutics Total Liabilities
87.41M78.68M74.4M83.43M61.51M66.33M41.94M47.38M32.85M37.38M
Minority Interest----------
Preferred Stock----------
Common Stock Net0.01M0.01M0.01M0.01M------
Capital Surplus1.5B1.49B1.1B1.09B957.6M947.82M941.35M926.76M920.86M905.33M
Retained Earnings-1.17B-1.08B-958.82M-899.05M-834.37M-782.43M-740.58M-679.02M-634.6M-605.38M
Treasury Stock----------
Other Liabilities-0.12M--0.01M-0.11M--0.01M-0.01M-0.09M-0.05M-0.03M
Sarepta Therapeutics Shareholders Equity
336.69M408.62M138.96M190.34M123.23M165.37M200.75M247.65M286.2M299.92M
Sarepta Therapeutics Total Liabilities & Shareholders Equity
424.1M487.31M213.36M273.78M184.75M231.71M242.7M295.03M319.05M337.3M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

1:11
SRPT

Sarepta Therapeutics Balance Sheet - Key Ratios

Current ratio
6.7
Debt to Equity ratio
0.05

Quarterly Balance Sheets For Sarepta Therapeutics Inc Peers

Aviragen Therapeutics balance sheet, BioCryst Pharma balance sheet, DBV Tech balance sheet, Gilead Sciences balance sheet, Halozyme Therapeutics balance sheet